Atlas Trials

TOward the Lowest Effective DOse of Abatacept or Tocilizumab

Clinical trial NCT01557374 · COMPLETED

Trial details

NCT number
NCT01557374
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2012-04-01
Primary completion
2019-11-08
Enrollment
232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.